IMPLANTABLE NANOCHANNEL DELIVERY DEVICES

Alessandro Grattoni; Edward Brian Butler; Ganesh Palapattu

IMPLANTABLE NANOCHANNEL DELIVERY DEVICES

Alessandro Grattoni (Inventor), Edward Brian Butler (Inventor), Ganesh Palapattu (Inventor)

Research output: Patent

Abstract

An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.

Original language	English (US)
Patent number	US2018125780
IPC	A61M 37/ 00 A I
Priority date	5/16/16
State	Published - May 10 2018

Divisions

Abdominal Transplant

Cite this

@misc{70787f7867eb442bba9fab0bb75fa085,

title = "IMPLANTABLE NANOCHANNEL DELIVERY DEVICES",

abstract = "An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.",

author = "Alessandro Grattoni and Butler, \{Edward Brian\} and Ganesh Palapattu",

year = "2018",

month = may,

day = "10",

language = "English (US)",

type = "Patent",

note = "US2018125780; A61M 37/ 00 A I",

}

TY - PAT

T1 - IMPLANTABLE NANOCHANNEL DELIVERY DEVICES

AU - Grattoni, Alessandro

AU - Butler, Edward Brian

AU - Palapattu, Ganesh

PY - 2018/5/10

Y1 - 2018/5/10

N2 - An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.

AB - An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.

M3 - Patent

M1 - US2018125780

ER -

IMPLANTABLE NANOCHANNEL DELIVERY DEVICES

Abstract

Divisions

Fingerprint

Cite this